scorecardresearch
Wednesday, April 24, 2024
TopicVaccine authorisation

Topic: Vaccine authorisation

SII to manufacture India’s first qHPV vaccine against cervical cancer after DCGI approval

Cervical cancer in India is the 2nd most frequent cancer among women between 15-44 years of age. Currently, India is fully dependent on foreign manufacturers for the vaccine.

Why you won’t get Covishield, Covaxin at a chemist yet, despite full market approval

Covishield and Covaxin have been fully authorised only for use in adults, and can only be used in a ‘programmatic setting’, which means you’ll still have to register on CoWin.

Novavax’s Covid vaccine, made by Serum Institute of India, gets emergency use nod in Indonesia

Serum Institute of India, world's largest vaccine manufacturer, will market the nanoparticle protein-based vaccine in Indonesia under the brand name Covovax.

On Camera

Imtiaz Ali obsesses over vulgarity, misses Chamkila’s cultural resistance against purity

Peter Manuel's ‘Cassette Culture’ showed the booming Bhakti music during the '80s and '90s when Anoop Jalota, Gulshan Kumar achieved success by singing the sanitised Bhajans.

Economists vs statisticians — the battle being fought over the soul of India’s GDP data

Economists say there are weaknesses in India’s GDP data. But statisticians claim the accusations are based on flawed understanding, saying while GDP has problems, the economists are looking in the wrong places.

India and Japan hold 10th round of consultations on disarmament, non-proliferation, and export control

The two sides also discussed ways to strengthen cooperation in outer space security, conventional weapons, and export control

These 6 states are key for Modi’s ‘400 paar’ target. They’re also where Opposition can stop him

While this contest looks so predictable in large swathes of our political landscape, it is also more keenly contested than 2019 in some states.